Keith L. Ligon, MD, PhD

Director, Center for Patient Derived Models, Dana-Farber Cancer Institute

Associate Professor of Pathology, Harvard Medical School

Chief, Division of Neuropathology, Brigham and Women’s Hospital
Office Phone: 617-632-2357
Fax: 617-632-8761
Preferred Contact Method: appointment phone


Treatment Centers
Oncologic Pathology
Clinical Interests
Developmental neuropathology, General neuropathology, Neuropathology of brain tumors


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215

Brigham and Women's Hospital
75 Francis Street
Boston, MA  02215


Board Certifications
Anatomic Pathology, 2001
Neuropathology, 2001
Brigham and Women's Hospital, Neuropathology, 2001
Brigham and Women's Hospital, Anatomic Pathology, 1999
Medical School
University of Texas Medical School at Houston, 1997
Dr. Ligon is a Physician-Scientist with expertise in neuropathology and oncology focused on improving the diagnosis and treatment of cancer. He attended medical school and received his PhD at the University of Texas-Houston Medical School and the M.D. Anderson Cancer Center. Currently he is an Associate Professor of Pathology at Harvard Medical School with joint appointments at the Dana-Farber Cancer Institute, the Broad Institute, and Brigham and Women’s Hospital (BWH). He is the Chief of Neuropathology at BWH/DFCI and the Director of the Center for Patient Derived Models (CPDM) at DFCI. His research and clinical activities have improved the scientific understanding of brain tumors. He is directly involved in the training of medical and graduate students, postdoctoral fellows, residents, and faculty. Several of the methods he has developed in his research have been implemented in the clinical pathology lab to improve patient diagnosis. He has also led efforts to train neuropathologists in the utilization of genomic tests in practice and led genomically informed clinical trials development at the local and national consortium levels.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.